Market News
Stay updated with the latest market trends, earnings, and economic indicators.
PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.
Laurus Labs shares are up 100% in the last 12 months and Motilal Oswal sees further upside
Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026 - Mint
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026Mint
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026
Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 20 February 2026 - Oil and Natural Gas Corporation (ONGC) and RBL Bank shares - and has suggested selling Info Edge (India) stock futures.
Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal
Motilal Oswal recommended is bullish on Niva Bupa Health Insurance recommended buy rating on the stock with a target price of Rs 100 in its research report dated Jun 19, 2026.
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
Motilal Oswal recommended is bullish on Five Star Business Finance recommended buy rating on the stock with a target price of Rs 600 in its research report dated Jun 22, 2026.
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.
Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal
Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5525 in its research report dated February 14, 2026.
Neutral Eris Lifesciences; target of Rs 1520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1520 in its research report dated February 14, 2026.
Neutral Lupin; target of Rs 2360: Motilal Oswal
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2360 in its research report dated February 14, 2026.
Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal
Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated February 14, 2026.